- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.80 Å
- Oligo State
- hetero-2-2-2-2-2-2-2-2-2-2-2-2-2-2-mer
- Ligands
- 8 x MG: MAGNESIUM ION(Non-covalent)
- 2 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)
- 2 x 37Y: N-(morpholin-4-ylacetyl)-D-alanyl-N-[(2S,4R)-1-cyclohexyl-5-hydroxy-4-methyl-3-oxopentan-2-yl]-O-methyl-L-tyrosinamide(Covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- De Bruin, G. et al., Structure-based design of beta 1i or beta 5i specific inhibitors of human immunoproteasomes. J.Med.Chem. (2014)
- Release Date
- 2014-07-23
- Peptides
- Proteasome subunit alpha type-2: AO
Proteasome subunit alpha type-3: BP
Proteasome subunit alpha type-4: CQ
Proteasome subunit alpha type-5: DR
Proteasome subunit alpha type-6: ES
Probable proteasome subunit alpha type-7: FT
Proteasome subunit alpha type-1: GU
Proteasome subunit beta type-2: HV
Proteasome subunit beta type-3: IW
Proteasome subunit beta type-4: JX
Proteasome subunit beta type-5: KY
Proteasome subunit beta type-6: LZ
Proteasome subunit beta type-7: M0
Proteasome subunit beta type-1: N1 - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AO
OB
BP
PC
CQ
QD
DR
RE
ES
SF
FT
TG
GU
UH
HV
VI
IW
WJ
JX
XK
KY
YL
LZ
ZM
M0
aN
N1
b